MDCX Stock Summary and Trading Ideas (Medicus Pharma Ltd. | NASDAQ:MDCX)

Medicus Pharma Ltd is a clinical-stage holding company focused on investing in and accelerating novel life sciences and bio-technology companies through FDA-approved clinical trials. The Company focuses on meeting the unmet need to improve patient safety and efficacy.

Medicus Pharma Ltd. trades on the NASDAQ stock market under the symbol MDCX.

As of December 26, 2025, MDCX stock price climbed to $1.57 with 243,251 million shares trading.

MDCX has a beta of 0.41, meaning it tends to be less sensitive to market movements. MDCX has a correlation of 0.00 to the broad based SPY ETF.

MDCX has a market cap of $38.67 million. This is considered a Sub-Micro Cap stock.

The top ETF exchange traded funds that MDCX belongs to (by Net Assets): IWC.

MDCX has underperformed the market in the last year with a price return of -44.9% while the SPY ETF gained +16.0%. MDCX has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -40.5% and -17.2%, respectively, while the SPY returned +4.6% and +1.5%, respectively.

MDCX support price is $1.43 and resistance is $1.67 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that MDCX shares will trade within this expected range on the day.